Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract
BMC Ophthalmology Jun 10, 2021
Ren Y, Du S, Zheng D, et al. - Researchers conducted this retrospective cohort study to assess the effectiveness and safety of phacoemulsification with intravitreal 3 mg triamcinolone acetonide injection in preventing postoperative inflammation and complications in patients with non-infectious anterior uveitis and panuveitis complicated cataract. From January 2018 to January 2020, 140 uveitic cataract patients who received phacoemulsification and intraocular lens implantation in Shanxi Eye hospital were reviewed. Intraoperative intravitreal injection of 3 mg triamcinolone acetonide is an effective and safe adjunctive therapy for preventing postoperative inflammation and complications and promoting early recovery in patients with anterior uveitis or panuveitis complicated cataracts after phacoemulsification.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries